Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study
Abstract Background MET amplification is associated with acquired resistance to first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) in treating non-small-cell lung cancer (NSCLC); however, the therapeutic strategy in these patients is undefined. Herein we repor...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2019-02-01
|
| coleção: | Journal of Translational Medicine |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1186/s12967-019-1803-9 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|